NEOG · NASDAQ
Neogen (NEOG) Stock Price & Fundamentals
Neogen (NEOG) closed at $787.35 on Oct 9, 2026, up 0.97% from the previous close of $779.78.
Share price, past year
1Y +22.51%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $787.35 |
| Sep 30, 2026 | $748.36 |
| Aug 31, 2026 | $776.27 |
| Jul 31, 2026 | $804.90 |
| Jun 30, 2026 | $780.47 |
| May 29, 2026 | $759.22 |
| Apr 30, 2026 | $765.71 |
| Mar 31, 2026 | $805.64 |
| Feb 27, 2026 | $832.99 |
| Jan 30, 2026 | $830.55 |
| Dec 31, 2025 | $805.60 |
| Nov 28, 2025 | $743.69 |
| Oct 31, 2025 | $693.00 |
Key statistics
- Market cap
- $171.88B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.26
- Revenue (TTM)
- $884.00M
- Net income (TTM)
- −$56.10M
- Shares outstanding
- 218.3M
- Dividend yield
- —
- 52-week range
- $642.68 – $863.73
Neogen's market cap is $171.88B, based on a share price of $787.35 and 218.3M shares outstanding as of Aug 31, 2026.
Financials
Neogen reported revenue of $870.40M for fiscal 2026, down 2.72% from fiscal 2025.
Neogen reported a net loss of $7.90M in fiscal 2026.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended May 31, 2026 | $870.40M | −2.7% | −$7.90M | −0.9% | −$0.04 | — |
| FY2025ended May 31, 2025 | $894.70M | −3.2% | −$1.09B | −122.1% | −$5.03 | — |
| FY2024ended May 31, 2024 | $924.20M | +12.4% | −$9.40M | −1.0% | −$0.04 | — |
| FY2023ended May 31, 2023 | $822.45M | +56.0% | −$22.87M | −2.8% | −$0.12 | — |
| FY2022ended May 31, 2022 | $527.16M | +12.5% | $48.31M | 9.2% | $0.45 | — |
| FY2021ended May 31, 2021 | $468.46M | +12.0% | $60.88M | 13.0% | $0.57 | — |
| FY2020ended May 31, 2020 | $418.17M | +1.0% | $59.48M | 14.2% | $0.56 | — |
| FY2019ended May 31, 2019 | $414.19M | +4.1% | $60.18M | 14.5% | $0.57 | — |
| FY2018ended May 31, 2018 | $397.93M | +11.1% | $63.15M | 15.9% | $1.21 | — |
| FY2017ended May 31, 2017 | $358.28M | — | $43.79M | 12.2% | $0.86 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2027ended Aug 31, 2026 | $222.80M | −$11.90M | −$0.05 |
| Q4 FY2026ended May 31, 2026 | $225.31M | −$11.28M | −$0.06 |
| Q3 FY2026ended Feb 28, 2026 | $211.20M | −$17.00M | −$0.08 |
| Q2 FY2026ended Nov 30, 2025 | $224.69M | −$15.92M | −$0.07 |
| Q1 FY2026ended Aug 31, 2025 | $209.20M | $36.30M | $0.17 |
| Q4 FY2025ended May 31, 2025 | $225.48M | −$612.21M | −$2.82 |
| Q3 FY2025ended Feb 28, 2025 | $221.00M | −$10.90M | −$0.05 |
| Q2 FY2025ended Nov 30, 2024 | $231.26M | −$456.28M | −$2.10 |
Company profile
- Name
- Neogen Corporation
- Ticker
- NEOG
- Exchange
- NASDAQ
- Industry (SEC SIC)
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- 620 Lesher Place, Lansing, MI 48912
- Incorporated in
- MI
- Fiscal year ends
- May
- SEC CIK
- 0000711377
Recent SEC filings
- Oct 7, 2026
- Oct 7, 2026
- Oct 6, 2026
- Aug 7, 2026
- Jul 30, 2026
- Jul 30, 2026
- Apr 20, 2026
- Apr 9, 2026
Frequently asked questions
What is Neogen's stock price?
Neogen (NEOG) closed at $787.35 on Oct 9, 2026, up 0.97% from the previous close of $779.78.
What is Neogen's market cap?
Neogen's market cap is $171.88B, based on a share price of $787.35 and 218.3M shares outstanding as of Aug 31, 2026.
How much revenue does Neogen make?
Neogen reported revenue of $870.40M for fiscal 2026, down 2.72% from fiscal 2025.
Does Neogen pay a dividend?
Neogen's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Neogen Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures